Social Media Ideas for Nature Biotechnology

Beyond the Wet Lab Bottleneck: The Race to Build Biology’s Generative Engine

Cambridge, MA – MIT Media Lab – EmTech Future. Nature has spent roughly 3.8 billion years conducting the most sprawling, creative research and development campaign in history. Evol...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

The collaboration brings together Synastra’s expertise in genomic engineering, AAV vector design, rare-disease gene therapy, and translational development with NewBiologix’s propri...

<![CDATA[Cellectis Transforming Into In Vivo Gene Editing Company]]>

Thirty Million Compartments: Testing Single-Molecule PCR’s Potential

Countable Labs has named Fred Hutchinson its first certified service provider, currently serving researchers across the Seattle region. And the company is continuing to build its l...

Exclusive-Anthropic quietly sets up biology lab as it ramps AI drug program

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...

APEC Holds High-Level Policy Dialogue on Agricultural Biotechnology

Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

Validated on the CellXpress.ai automated cell culture system, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability,...

Great gene editing. Now prove it without overcomplicating the analysis

Gene editing is moving from lab bench to approved therapies. But how should sponsors measure editing efficiency without unnecessary complexity? The post Great gene editing. Now pro...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

A new study showed that a programmed lysis approach cut mechanical separation energy by over 50 percent at pilot scale, widening the range of bioalternatives that can compete price...

「天然の応用」から「1兆通りの探索」へ発想転換　ペプチド創薬加速

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

Under the agreement, Andelyn will transition Genprex's adeno-associated virus (AAV)-based diabetes gene therapy candidate with process optimization, scale-up, and IND-enabling and...

Extracellular Secretion System Could Solve Industry Endonuclease Production Challenges

A new extracellular secretion system could help biopharmaceutical manufacturers bypass the problems that make traditional Escherichia coli-based recombinant endonuclease production...

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

JNC Targets Bigger Molecules with Cellufine

JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, va...

<![CDATA[The Future of Precision Medicine Depends on More Than Biology]]>

He Won the Nobel Prize for Protein Design. Now He Uses AI to Create Molecules Not Found in Nature

David Baker spoke with WIRED en Español about where biological design is headed next and the great potential and risks of taking biology outside the bounds of the natural world.

The Top 10 Questions Shaping the Future of Optogenetic Biomanufacturing

This article explores the ten most important questions facing optogenetic biomanufacturing as it moves from proof‑of‑concept demonstrations toward mainstream adoption in modern bio...

AI-driven drug discovery race: Anthropic quietly opens biology laboratory in major push

While many AI companies rely exclusively on public datasets and external academic partnerships to train computational models, running an in-house laboratory allows researchers to p...

Anthropic says Claude discovers novel enzyme system with CRISPR-like properties

The discovery marks Anthropic’s first reported result from its biology research as the AI company expands into life sciences

Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology

Transcenta, headquartered in China and with a pipeline of over ten therapeutic antibody candidates, is a clinical-stage biopharmaceutical company with expertise in biologics discov...

Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models

The collaboration pairs the Genialis Supermodel with Inventia Life Science’s RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology o...

The hidden scale-out problem behind CAR-T’s growth

CAR-T’s commercial challenge is making thousands of patient-specific manufacturing runs behave like one reliable system. "In vivo" production techniques could be one solution.

Biologics Standards for Innovation, Quality and Access

This GEN Spotlight on Biologics Standards for Innovation, Quality and Access brings together experts from across biopharma, standards development, and analytical science to examine...